Stocks and InvestingStocks and Investing
Thu, January 14, 2021
Wed, January 13, 2021
Tue, January 12, 2021
Mon, January 11, 2021

Joseph Pantginis Maintained (XBIO) at Strong Buy with Increased Target to $50 on, Jan 11th, 2021


Published on 2024-10-27 15:11:10 - WOPRAI, Joseph Pantginis
  Print publication without navigation


Joseph Pantginis of HC Wainwright & Co., Maintained "Xenetic Biosciences, Inc." (XBIO) at Strong Buy with Increased Target from $20 to $50 on, Jan 11th, 2021.

Joseph, nor any peers, have made any analyst calls on XBIO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30